Explore Top Tech Companies
All Filters
Location

Remote jobs

Industry

DEI

Tech Stack

Perks

Size

Top New Orleans, LA Biotech Companies (6)

Don't see your company?

Create a company profile
Biotech
New Orleans, Louisiana, USA

Bovigen LLC, a genomics company, engages in the development, validation, and commercialization of genetic tools that enable producers to


Big Data • Analytics • Biotech
New Orleans, Louisiana, USA
19 Employees

Pine Biotech brings computational big-data analysis tools to the Agrotech and Biotech industries to address industry-specific challenges.


Biotech
New Orleans, Louisiana, USA
5 Employees

Bioceptive, a women’s health company, develops an intrauterine device inserter that simplifies the insertion procedure.


Biotech
New Orleans, Louisiana, USA
16 Employees

Obatala Sciences offers contract research services and research products to laboratories in industry and in academia. Our clients include major pharmaceutical companies, US government entities, contract research organizations, non-profit organizations, and academic research laboratories. Our areas of expertise include obesity, diabetes, energy metabolism, musculoskeletal system biology, and wound healing. ObaCell™, a unique fat tissue model, is a great tool for disease modeling and drug screening. Obatala Sciences can provide data in various areas depending on your interest including proteomics, genomics, functionality, and adipokine secretion. We also have the capability of forming white or brown fat tissue upon request.


Biotech
New Orleans, Louisiana, USA
25 Employees

Revolo Biotherapeutics is developing revolutionary therapies powered to reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases. Its two drug candidates, ‘1805 and ‘1104, a protein and a peptide respectively, reset the immune system by preventing the chronic pro-inflammatory immune response that results in autoimmune or allergic disease. ‘1805 is a modified analogue of a key molecule in immune function and is in clinical development for moderate-to-severe rheumatoid arthritis and non-infectious uveitis. ‘1104 is a peptide derived from a natural immune-regulatory protein and is in clinical development for patients with eosinophilic esophagitis (EoE) and allergic disease. The disease-agnostic mechanism of action of Revolo Biotherapeutic’s assets provides a potential platform for the development of treatments for multiple autoimmune and allergic diseases. Visit www.revolobio.com to learn more.


Biotech • Pharmaceutical
New Orleans, Louisiana, USA
29 Employees

AxoSim is an operator of a biomimetic neuroscience discovery platform used to develop a 3D cell-based platform.